(Q53260004)

12 May 2018

title

Preparation of a chemically stable quercetin formulation using nanosuspension technology (English)

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

31 August 2024

author name string

Lei Gao

1

1 reference

12 May 2018

Guiyang Liu

2

1 reference

12 May 2018

Xiaoqing Wang

3

1 reference

12 May 2018

Fei Liu

4

1 reference

12 May 2018

Yuefang Xu

5

1 reference

12 May 2018

Jing Ma

6

1 reference

12 May 2018

language of work or name

English

0 references

publication date

17 November 2010

1 reference

12 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0378517310008586?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

https://api.elsevier.com/content/article/PII:S0378517310008586?httpAccept=text/plain

31 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

International Journal of Pharmaceutics

31 August 2024

published in

1 reference

12 May 2018

volume

404

1 reference

12 May 2018

issue

1-2

1 reference

12 May 2018

page(s)

231-237

1 reference

12 May 2018

Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors.

31 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Pharmacokinetics and bioavailability of herbal medicinal products.

31 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs.

31 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Quercetin/beta-cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixture

31 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Effects of alpha- and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones.

31 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents

31 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution

31 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement

31 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

What is the true solubility advantage for amorphous pharmaceuticals?

31 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance

31 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine

31 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base

31 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Dietary flavonoids: intake, health effects and bioavailability

31 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

31 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Disposition of the Flavonoid Quercetin in Rats After Single Intravenous and Oral Doses

31 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method

31 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Nanosizing: a formulation approach for poorly-water-soluble compounds

31 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells

31 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability

31 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles

31 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Nanosuspensions: a promising drug delivery strategy.

31 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene

31 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.

31 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Nanosuspensions in drug delivery

31 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Enhanced drug dissolution using evaporative precipitation into aqueous solution.

31 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Incorporation of quercetin in lipid microparticles: effect on photo- and chemical-stability

31 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology

31 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.

31 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

Production and characterization of a spray-dried hydroxypropyl-beta-cyclodextrin/quercetin complex

31 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2010.11.009

31 August 2024

Identifiers

1 reference

12 May 2018

1 reference

12 May 2018